(2-(trimethylammonium)ethyl)methanethiosulfonate has been researched along with arginine in 6 studies
| Studies ((2-(trimethylammonium)ethyl)methanethiosulfonate) | Trials ((2-(trimethylammonium)ethyl)methanethiosulfonate) | Recent Studies (post-2010) ((2-(trimethylammonium)ethyl)methanethiosulfonate) | Studies (arginine) | Trials (arginine) | Recent Studies (post-2010) (arginine) |
|---|---|---|---|---|---|
| 143 | 0 | 17 | 46,388 | 1,688 | 11,176 |
| Protein | Taxonomy | (2-(trimethylammonium)ethyl)methanethiosulfonate (IC50) | arginine (IC50) |
|---|---|---|---|
| Cationic amino acid transporter 3 | Homo sapiens (human) | 283 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawson, DC; Kriewall, TE; Liu, X; McCarty, NA; Smith, SS; Sun, F; Zhang, ZR | 1 |
| Dawson, DC; Liu, X; Smith, SS; Sun, F | 1 |
| Alexeyev, MF; Winkler, HH | 1 |
| Clements, JD; Han, NL; Lynch, JW | 1 |
| Chikina, MD; Glaaser, IW; Hanck, DA; Lam, AD; McNulty, MM | 1 |
| Cui, J; Delaloye, K; Nekouzadeh, A; Rudy, Y; Wu, D; Zaydman, MA | 1 |
6 other study(ies) available for (2-(trimethylammonium)ethyl)methanethiosulfonate and arginine
| Article | Year |
|---|---|
CFTR: covalent and noncovalent modification suggests a role for fixed charges in anion conduction.
Topics: Animals; Anions; Arginine; Cysteine; Cystic Fibrosis Transmembrane Conductance Regulator; Disulfides; Electric Conductivity; Ethyl Methanesulfonate; Female; Humans; Hydrogen-Ion Concentration; Lysine; Membrane Potentials; Mercaptoethanol; Mesylates; Models, Biological; Oocytes; Patch-Clamp Techniques; Perfusion; Xenopus | 2001 |
CFTR: covalent modification of cysteine-substituted channels expressed in Xenopus oocytes shows that activation is due to the opening of channels resident in the plasma membrane.
Topics: Amino Acid Substitution; Animals; Arginine; Brefeldin A; Cell Membrane; Cyclic AMP; Cysteine; Cystic Fibrosis Transmembrane Conductance Regulator; Electric Conductivity; Female; Mesylates; Microinjections; Mutagenesis, Site-Directed; Oocytes; Protein Synthesis Inhibitors; RNA, Complementary; Time Factors; Xenopus | 2001 |
Complete replacement of basic amino acid residues with cysteines in Rickettsia prowazekii ATP/ADP translocase.
Topics: Amino Acids, Basic; Arginine; Cysteine; Cytoplasm; Kinetics; Lysine; Mesylates; Mitochondrial ADP, ATP Translocases; Mutagenesis, Site-Directed; Mutation; Periplasm; Protein Structure, Tertiary; Rickettsia prowazekii | 2002 |
Comparison of taurine- and glycine-induced conformational changes in the M2-M3 domain of the glycine receptor.
Topics: Arginine; Binding Sites; DNA, Complementary; Dose-Response Relationship, Drug; Electrophysiology; Glycine; Humans; Inhibitory Concentration 50; Kinetics; Lysine; Mesylates; Mutagenesis, Site-Directed; Mutation; Protein Conformation; Protein Structure, Tertiary; Receptors, Glycine; Sulfhydryl Reagents; Taurine; Time Factors | 2004 |
Role of Domain IV/S4 outermost arginines in gating of T-type calcium channels.
Topics: Amino Acid Substitution; Arginine; Binding Sites; Calcium Channels, T-Type; Cell Line; Ethyl Methanesulfonate; Gene Expression; Humans; Hydrogen-Ion Concentration; Ion Channel Gating; Mesylates; Patch-Clamp Techniques; Sulfhydryl Reagents; Transfection | 2005 |
State-dependent electrostatic interactions of S4 arginines with E1 in S2 during Kv7.1 activation.
Topics: Amino Acid Sequence; Animals; Arginine; Cell Membrane; Cysteine; Ion Channel Gating; KCNQ1 Potassium Channel; Long QT Syndrome; Membrane Potentials; Mesylates; Models, Molecular; Molecular Sequence Data; Mutation; Protein Conformation; Protein Structure, Tertiary; Protein Transport; Sulfhydryl Reagents; Surface Properties; Time Factors; Xenopus | 2010 |